149 related articles for article (PubMed ID: 32113001)
1. Factors associated with extremely high progesterone concentrations on the day of HCG administration.
Tsai YR; Lin YJ; Lin YC; Hsu TY; Lan KC
J Gynecol Obstet Hum Reprod; 2020 Oct; 49(8):101720. PubMed ID: 32113001
[TBL] [Abstract][Full Text] [Related]
2. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
[TBL] [Abstract][Full Text] [Related]
3. Impact of endogenous luteinizing hormone serum levels on progesterone elevation on the day of human chorionic gonadotropin administration.
Hugues JN; Massé-Laroche E; Reboul-Marty J; Boîko O; Meynant C; Cédrin-Durnerin I
Fertil Steril; 2011 Sep; 96(3):600-4. PubMed ID: 21880277
[TBL] [Abstract][Full Text] [Related]
4. Effect of progesterone/estradiol ratio on pregnancy outcome of patients with high trigger-day progesterone levels undergoing gonadotropin-releasing hormone antagonist intracytoplasmic sperm injection cycles: a retrospective cohort study.
Golbasi H; Ince O; Golbasi C; Ozer M; Demir M; Yilmaz B
J Obstet Gynaecol; 2019 Feb; 39(2):157-163. PubMed ID: 30280612
[TBL] [Abstract][Full Text] [Related]
5. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
[TBL] [Abstract][Full Text] [Related]
6. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
[TBL] [Abstract][Full Text] [Related]
7. GnRH antagonist administered twice the day before hCG trigger combined with a step-down protocol may prevent OHSS in IVF/ICSI antagonist cycles at risk for OHSS without affecting the reproductive outcomes: a prospective randomized control trial.
Prapas Y; Ravanos K; Petousis S; Panagiotidis Y; Papatheodorou A; Margioula-Siarkou C; Iuliano A; Gullo G; Prapas N
J Assist Reprod Genet; 2017 Nov; 34(11):1537-1545. PubMed ID: 28776117
[TBL] [Abstract][Full Text] [Related]
8. Timing of human chorionic gonadotropin (hCG) hormone administration in IVF/ICSI protocols using GnRH agonist or antagonists: a systematic review and meta-analysis.
Chen Y; Zhang Y; Hu M; Liu X; Qi H
Gynecol Endocrinol; 2014 Jun; 30(6):431-7. PubMed ID: 24731070
[TBL] [Abstract][Full Text] [Related]
9. Supplementation with human menopausal gonadotropin in the gonadotropin-releasing hormone antagonist cycles of women with high AMH: Pregnancy outcomes and serial hormone levels.
Chen LH; Chin TH; Huang SY; Yu HT; Chang CL; Huang HY; Wang HS; Soong YK; Wu HM
Taiwan J Obstet Gynecol; 2021 Jul; 60(4):739-744. PubMed ID: 34247817
[TBL] [Abstract][Full Text] [Related]
10. GnRH agonist versus HCG triggering in different IVF/ICSI cycles of same patients: a retrospective study.
Yılmaz N; Ceran MU; Ugurlu EN; Gülerman HC; Engin Ustun Y
J Obstet Gynaecol; 2020 Aug; 40(6):837-842. PubMed ID: 31791167
[TBL] [Abstract][Full Text] [Related]
11. Progesterone/estradiol ratio <0.25 on the day of human chorionic gonadotropin administration is associated with adverse pregnancy outcomes in prolonged protocols for in vitro fertilization/intracytoplasmic sperm injection.
Li Y; Luo K; Tang Y; Lin G; Lu G; Gong F
Taiwan J Obstet Gynecol; 2017 Feb; 56(1):27-31. PubMed ID: 28254221
[TBL] [Abstract][Full Text] [Related]
12. Exploration of the value of progesterone and progesterone/estradiol ratio on the hCG trigger day in predicting pregnancy outcomes of PCOS patients undergoing IVF/ICSI: a retrospective cohort study.
Yang Y; Liu B; Wu G; Yang J
Reprod Biol Endocrinol; 2021 Dec; 19(1):184. PubMed ID: 34893087
[TBL] [Abstract][Full Text] [Related]
13. The impact of LH, E2, and P level of HCG administration day on outcomes of in vitro fertilization in controlled ovarian hyperstimulation.
Wei M; Zhang XM; Gu FL; Lv F; Ji YR; Liu KF; She H; Hu R
Clin Exp Obstet Gynecol; 2015; 42(3):361-6. PubMed ID: 26152012
[TBL] [Abstract][Full Text] [Related]
14. The duration of pre-ovulatory serum progesterone elevation before hCG administration affects the outcome of IVF/ICSI cycles.
Huang CC; Lien YR; Chen HF; Chen MJ; Shieh CJ; Yao YL; Chang CH; Chen SU; Yang YS
Hum Reprod; 2012 Jul; 27(7):2036-45. PubMed ID: 22561057
[TBL] [Abstract][Full Text] [Related]
15. Optimizing FSH Concentration Modulation in the Short-Acting GnRH-a Long Protocol for IVF/ICSI: A Retrospective Study.
Hu L; Bai L; Qin R; Wang X; Zhou J; Yu C; Chen Y; Wang S; Zhao S; Chen L; Lu R
Adv Ther; 2024 Jan; 41(1):215-230. PubMed ID: 37884809
[TBL] [Abstract][Full Text] [Related]
16. The comparison of microdose flare-up and multiple dose antagonist protocols based on hCG day estradiol (E2), progesterone (P) and P/E2 ratio among poor responder patients in ICSI-ET cycles.
Cicek MN; Kahyaoglu I; Kahyaoglu S
Eur Rev Med Pharmacol Sci; 2015 Feb; 19(4):539-44. PubMed ID: 25753867
[TBL] [Abstract][Full Text] [Related]
17. Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles.
Xu B; Li Z; Zhang H; Jin L; Li Y; Ai J; Zhu G
Fertil Steril; 2012 Jun; 97(6):1321-7.e1-4. PubMed ID: 22494924
[TBL] [Abstract][Full Text] [Related]
18. Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles.
Wu Z; Li R; Ma Y; Deng B; Zhang X; Meng Y; Chen X; Liu P; Qiao J
Reprod Biomed Online; 2012 May; 24(5):511-20. PubMed ID: 22417667
[TBL] [Abstract][Full Text] [Related]
19. Is the effect of premature elevated progesterone augmented by human chorionic gonadotropin versus gonadotropin-releasing hormone agonist trigger?
Connell MT; Patounakis G; Healy MW; DeCherney AH; Devine K; Widra E; Levy MJ; Hill MJ
Fertil Steril; 2016 Sep; 106(3):584-589.e1. PubMed ID: 27178228
[TBL] [Abstract][Full Text] [Related]
20. Progesterone change in the late follicular phase affects pregnancy rates both agonist and antagonist protocols in normoresponders: a case-controlled study in ICSI cycles.
Demir B; Kahyaoglu I; Guvenir A; Yerebasmaz N; Altinbas S; Dilbaz B; Dilbaz S; Mollamahmutoglu L
Gynecol Endocrinol; 2016; 32(5):361-5. PubMed ID: 26654315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
